Baida Group Co.,Ltd (SHA:600865)

Intra-Cellular Therapies Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	80.61	69.24	193.97	88.68	138.12	202.84
Short-Term Investments	60.34	60.34	150.33	241.67	187.72	302.67
Trading Asset Securities	1,216	1,255	848.28	962.73	714.89	629.16
Cash & Short-Term Investments	1,357	1,384	1,193	1,293	1,041	1,135
Cash Growth	4.28%	16.07%	-7.77%	24.25%	-8.28%	4.36%
Accounts Receivable	18.35	23.62	22.42	27.32	22.44	19.77
Other Receivables	6.37	5.33	2.66	2.84	0.32	3.36
Receivables	24.72	28.95	25.08	30.16	86.32	224.09
Inventory	1.12	0.73	0.3	0.73	0.88	0.88
Prepaid Expenses	-	0	0.07	1.89	0.17	0
Other Current Assets	3.37	0.78	1.03	2.05	1.85	0.98
Total Current Assets	1,386	1,415	1,219	1,328	1,130	1,361
Property, Plant & Equipment	68.71	73.49	62.24	79.53	83.66	88.96
Long-Term Investments	963.64	955.96	1,108	1,114	1,155	956.6
Other Intangible Assets	43.57	43.99	43.72	47.48	51.44	55.09
Long-Term Deferred Tax Assets	5.59	4.9	7.67	5.41	10.68	2.19
Long-Term Deferred Charges	48.04	48.37	41.17	43.64	52.12	71.44
Other Long-Term Assets	25.37	26.02	54.13	60.05	65.98	71.91
Total Assets	2,541	2,567	2,536	2,678	2,624	2,607
Accounts Payable	40.46	65.02	67.41	63.36	70.7	97.71
Accrued Expenses	5.62	18.49	31.19	19.44	42.86	19.1
Short-Term Debt	-	-	-	-	-	50.06
Current Income Taxes Payable	8.34	16.24	17.16	33.18	42.93	24.78
Current Unearned Revenue	37.28	35.23	55	57.96	58.4	62.8
Other Current Liabilities	55.67	49.98	47.19	58.02	54.73	68.64
Total Current Liabilities	147.37	184.96	217.95	231.97	269.62	323.08
Long-Term Unearned Revenue	17.81	18.9	23.3	27.95	31.16	35.58
Long-Term Deferred Tax Liabilities	1.55	5.4	1.09	42.5	52.04	89.9
Other Long-Term Liabilities	16.27	16.76	-	-	-	-
Total Liabilities	183	226.01	242.35	302.43	352.83	448.57
Common Stock	376.24	376.24	376.24	376.24	376.24	376.24
Additional Paid-In Capital	233.87	233.87	233.87	233.66	233.46	233.46
Retained Earnings	1,748	1,731	1,685	1,765	1,661	1,548
Comprehensive Income & Other	-	-	-2.06	0.15	-	-
Total Common Equity	2,358	2,341	2,293	2,375	2,270	2,158
Minority Interest	0.24	0.26	0.31	0.2	0.24	0.48
Shareholders' Equity	2,358	2,341	2,293	2,376	2,271	2,158
Total Liabilities & Equity	2,541	2,567	2,536	2,678	2,624	2,607
Total Debt	-	-	-	-	-	50.06
Net Cash (Debt)	1,357	1,384	1,193	1,293	1,041	1,085
Net Cash Growth	4.28%	16.07%	-7.77%	24.25%	-4.05%	-0.24%
Net Cash Per Share	3.45	3.65	3.51	3.45	2.77	2.87
Filing Date Shares Outstanding	376.24	376.24	376.24	376.24	376.24	376.24
Total Common Shares Outstanding	376.24	376.24	376.24	376.24	376.24	376.24
Working Capital	1,239	1,230	1,001	1,096	860.33	1,038
Book Value Per Share	6.27	6.22	6.09	6.31	6.03	5.74
Tangible Book Value	2,314	2,297	2,249	2,328	2,219	2,103
Tangible Book Value Per Share	6.15	6.11	5.98	6.19	5.90	5.59
Buildings	-	253.84	152.87	152.87	152.87	152.87
Machinery	-	139.21	142.77	142.28	139.25	141.6
Construction In Progress	-	4.09	0.55	6.68	2.21	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.